Holles Natalie C. 4

What Happened

• Natalie C. Holles, a director of LeonaBio, received a grant of 2,333 derivative shares (reported as an award) on June 23, 2026. The filing reports the acquisition at $0.00 per share because this is a compensation award (a derivative grant), not an open‑market purchase or sale.

Key Details

• Transaction date and price: June 23, 2026; 2,333 shares at $0.00 (derivative award).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: The award is an option-like grant that vests on the earlier of (i) June 23, 2027 or (ii) the day before the next annual stockholders’ meeting after June 22, 2026. The grant was made under the company’s Outside Director Compensation Policy and is pro‑rated because Holles joined the board on May 5, 2026.
• Filing timeliness: Reported on Form 4 filed 2026-06-24 for a 2026-06-23 transaction — appears to be filed timely.

Context

• This is a routine outside-director compensation award rather than a market purchase or sale; it does not reflect an immediate cash outlay or sale of shares. The award vests in the future per the schedule above, and any future exercises or sales would be reported separately. Awards to outside directors are common and are often pro‑rated for mid‑year appointments.